

Ozempic and Wegovy were designed for diabetes and weight loss, but a growing body of evidence suggests they may quiet cravings across nearly every major addiction. At NatCon 2026, an addiction physician at Caron Treatment Centers walked attendees through the science and what patients should know.

A White House executive order in April 2026 dramatically accelerated FDA review of psychedelic drugs. Days later, three leaders in interventional psychiatry took the stage at NatCon 2026 to explain what’s actually here, what’s coming, and what patients should know before saying yes to any of it.

Access to care is evolving rapidly, and